Age: 74.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Hypotension
Clinical narrative: Dehydration; Conditions worsensing; lowered her BP; Dementia woresened; Weakness; became weak and had trouble inhaling her inbrija having more problems within the last few days since she got her 2nd covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA (Dementia woresened), DEHYDRATION (Dehydration), CONDITION AGGRAVATED (Conditions worsensing) and HYPOTENSION (lowered her BP) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product LEVODOPA (INBRIJA) for Parkinson's disease.    The patient's past medical history included Dehydration. Concurrent medical conditions included Parkinson's disease, On and off phenomenon, Non-tobacco user, Hypotension and Dementia. Concomitant products included CARBIDOPA, LEVODOPA (RYTARY) for Parkinson's disease, CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA) for an unknown indication.   On 04-Feb-2021, the patient started LEVODOPA (INBRIJA) (unknown route) 42 milligram twice a day. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEMENTIA (Dementia woresened) (seriousness criterion medically significant), DEHYDRATION (Dehydration) (seriousness criterion hospitalization), CONDITION AGGRAVATED (Conditions worsensing) (seriousness criterion hospitalization), ASTHENIA (Weakness), DEVICE DIFFICULT TO USE (became weak and had trouble inhaling her inbrija having more problems within the last few days since she got her 2nd covid vaccine) and HYPOTENSION (lowered her BP) (seriousness criterion hospitalization). At the time of the report, DEMENTIA (Dementia woresened) and DEHYDRATION (Dehydration) outcome was unknown and CONDITION AGGRAVATED (Conditions worsensing), ASTHENIA (Weakness), DEVICE DIFFICULT TO USE (became weak and had trouble inhaling her inbrija having more problems within the last few days since she got her 2nd covid vaccine) and HYPOTENSION (lowered her BP) was resolving.            No treatment information was provided.  On an unknown date, the patient had developed low blood pressure.  This case concerns a 74-year-old female with adverse events of Dehydration, condition aggravated, asthenia, device difficult to use and Dyspnea and was subsequently hospitalized after unknown days of Latency after mRNA-1273 vaccination and with co-suspect Levodopa (Inbrija) for Parkinson's Disease. There is very limited information available as temporal association cannot be established (missing dates of administration of both Moderna COVID Vaccine and Levodopa).; Sender's Comments: This case concerns a 74-year-old female with adverse events of Dehydration, condition aggravated, asthenia, device difficult to use and Dyspnea and was subsequently hospitalized after unknown days of Latency after mRNA-1273 vaccination and with co-suspect Levodopa (Inbrija) for Parkinson's Disease. There is very limited information available as temporal association cannot be established (missing dates of administration of both Moderna COVID Vaccine and Levodopa).